Tech-investor Epiq Capital Fund II closes at $225-M

Epiq Capital, a growth and late-stage tech investment firm, has announced the final closing of Epiq Capital II, which was oversubscribed at USD 225 million. The fund has domestic and global investors, including tech entrepreneurs, industrialists, sports and entertainment leaders, family offices, and sovereign wealth funds. Its current portfolio includes eyewear unicorn Lenskart, local language content platform Dailyhunt, fitness platform Curefit , SaaS platform Builder.ai, and health-tech company Pristyncare.